查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611389

短讀定序市場：按技術、產品、工作流程、應用程式和最終用戶分類 - 2025-2030 年全球預測

Short-read Sequencing Market by Technology (Next-Generation Sequencing, Sanger Sequencing), Product (Consumables, Instruments, Services), Workflow, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

短讀定序市場2023年估值為58.1億美元，預計2024年將達到67.3億美元，複合年成長率為15.98%，2030年將達到164.1億美元。

短讀長定序是一種用於對短 DNA 片段進行定序的高通量技術，在基因組學研究、個人化醫療和生物技術中至關重要。它對於全基因組關聯研究、單細胞定序和診斷測試至關重要，並因其經濟性、效率和準確性而受到重視。主要應用包括遺傳疾病診斷、癌症基因組學和農業生物技術，主要最終用戶為研究機構、診斷實驗室和製藥公司。由於技術進步、定序成本降低以及個人化醫療需求的增加，該市場正在蓬勃發展。與生物資訊學和人工智慧的整合進行資料分析增加了其效用。然而，短讀長無法處理重複區域或複雜的基因組組裝，因此在沒有長讀長技術支援的情況下，它們存在準確性和解釋問題等限制。有關基因組資料隱私的道德問題和監管複雜性也對市場成長構成挑戰。透過結合短讀和長讀的混合方法以及改進資料解釋演算法，有很多機會可以提高定序準確性。創新還可以集中於開發可攜式定序設備、擴展雲端基礎的基因組資料解決方案，以及將定序整合到各種醫療保健應用的照護現場診斷中。該市場的特點是快速創新、競爭激烈和多體學方法的整合。公司應投資研發，以改善技術、解決資料隱私問題，並倡導相關人員持續參與，以有效應對監管環境。此外，與人工智慧和生物資訊公司的策略夥伴關係可以在資料處理能力、個人化醫療創新和拓展開拓市場方面提供優勢。隨著該領域的發展，相關人員必須專注於透過增強的定序解決方案創造價值，以解決當前的限制和新興的醫療保健需求。

主要市場統計
基準年[2023] 58.1億美元
預計年份 [2024] 67.3億美元
預測年份 [2030] 164.1億美元
複合年成長率（%） 15.98%

市場動態：揭示快速發展的短讀定序市場的關鍵市場洞察

供需的動態交互作用正在改變短讀定序市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對個人化醫療和伴同性診斷的需求不斷成長
    • 臨床研究未知基因突變檢測的低成本定序需求增加
    • 腫瘤學、感染疾病、生殖篩檢和藥物基因組學等應用領域的需求快速成長
  • 市場限制因素
    • 缺乏熟練的專業人員，高成本
  • 市場機會
    • 持續開發降低基因組定序成本
    • 加強基因序列測定合作
  • 市場挑戰
    • 新興國家缺乏必要的基礎設施

波特五力：駕馭短讀定序市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解短讀定序市場的外部影響

外部宏觀環境因素在塑造短讀定序市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解短讀長定序市場的競爭格局

對短讀定定序市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣短讀定序市場供應商績效評估

FPNV定位矩陣是評估短讀長定序市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了短讀定序市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，短讀定定序市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對個人化醫療和伴同性診斷的需求不斷成長
      • 由於臨床研究中用於檢測未知基因突變的低成本定序的需求不斷增加
      • 腫瘤學、感染疾病、生殖篩檢和藥物基因組學等應用領域的需求快速成長
    • 抑制因素
      • 缺乏熟練的專業人員，高成本
    • 機會
      • 持續開發降低基因組定序成本
      • 擴大基因序列分析合作
    • 任務
      • 新興國家缺乏必要的基礎設施
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章短讀定定序市場：依技術分類

  • 次世代定序
  • 桑格序列

第 7 章短讀定定序市場：依產品

  • 消耗品
  • 裝置
  • 服務

第 8 章短讀定定序市場：依工作流程

  • 資料分析
  • 前序
  • 定序

第9章短讀定定序市場：依應用分類

  • 農業基因組學與法醫學
  • 臨床調查
  • 消費者基因體學
  • HLA型檢測和免疫系統監測
  • 總體基因體學、流行病學、藥物開發
  • 腫瘤學
  • 生殖健康

第 10 章 短讀定定序市場：依最終使用者分類

  • 學術研究
  • 臨床調查
  • 醫院/診所
  • 製藥和生物技術公司

第11章美洲短讀定序市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太短讀定序市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲短讀定序市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Almac Group
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Eurofins Genomics LLC
  • F. Hoffmann La Roche AG
  • General Electric Company
  • Genexa AG
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Seven Bridges Genomics, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD898498

The Short-read Sequencing Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.73 billion in 2024, and is projected to grow at a CAGR of 15.98%, to USD 16.41 billion by 2030.

Short-read sequencing is a high-throughput technology used to determine the sequence of short DNA fragments, pivotal in genomics research, personalized medicine, and biotechnology. It is indispensable for genome-wide association studies, single-cell sequencing, and diagnostic testing due to its affordability, efficiency, and accuracy. Key applications include genetic disorder diagnostics, cancer genomics, and agricultural biotechnology with major end-users being research institutions, diagnostic labs, and pharmaceutical companies. The market is buoyed by technological advancements, decreasing sequencing costs, and increasing demand for personalized medicine. Integration with bioinformatics and AI for data analysis enhances its utility. However, limitations include short reads' inability to span repetitive regions and complex genome assemblies, leading to challenges in accuracy and interpretation without the support of long-read technologies. The market growth is also challenged by ethical issues concerning genomic data privacy and regulatory complexities. Numerous opportunities lie in enhancing sequencing accuracy through hybrid approaches combining short and long reads or improving algorithms for data interpretation. Innovation can also focus on developing portable sequencing devices, expanding cloud-based genomic data solutions, and integrating sequencing into point-of-care diagnostics for broader healthcare applications. The market is characterized by rapid innovation, competitive collaboration, and integration of multi-omics approaches. Companies should invest in R&D to refine technologies, address data privacy concerns, and advocate for continuous stakeholder engagement to navigate regulatory landscapes effectively. Strategic partnerships with AI and bioinformatics firms can also provide an edge in data handling capabilities, personalized medicine innovations, and expansion into untapped markets. As the field evolves, stakeholders must focus on creating value through enhanced sequencing solutions that address both current limitations and emerging healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 5.81 billion
Estimated Year [2024] USD 6.73 billion
Forecast Year [2030] USD 16.41 billion
CAGR (%) 15.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Short-read Sequencing Market

The Short-read Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for personalized medicine and companion diagnostics
    • Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
    • Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
  • Market Restraints
    • Shortage of skilled professionals and high cost
  • Market Opportunities
    • Ongoing developments to decrease the cost of genome sequencing
    • Growing collaboration for genetic sequencing
  • Market Challenges
    • Dearth of required infrastructure in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Short-read Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Short-read Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Short-read Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Short-read Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Short-read Sequencing Market

A detailed market share analysis in the Short-read Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Short-read Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Short-read Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Short-read Sequencing Market

A strategic analysis of the Short-read Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Short-read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Almac Group, Azenta Life Sciences, BGI Genomics Co., Ltd., Eurofins Genomics LLC, F. Hoffmann La Roche AG, General Electric Company, Genexa AG, GenScript Biotech Corporation, Illumina, Inc., PerkinElmer, Inc., Qiagen N.V., Seven Bridges Genomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Short-read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Next-Generation Sequencing and Sanger Sequencing.
  • Based on Product, market is studied across Consumables, Instruments, and Services.
  • Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
  • Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing & Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
  • Based on End-User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for personalized medicine and companion diagnostics
      • 5.1.1.2. Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
      • 5.1.1.3. Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of skilled professionals and high cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing developments to decrease the cost of genome sequencing
      • 5.1.3.2. Growing collaboration for genetic sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of required infrastructure in emerging economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Short-read Sequencing Market, by Technology

  • 6.1. Introduction
  • 6.2. Next-Generation Sequencing
  • 6.3. Sanger Sequencing

7. Short-read Sequencing Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Instruments
  • 7.4. Services

8. Short-read Sequencing Market, by Workflow

  • 8.1. Introduction
  • 8.2. Data Analysis
  • 8.3. Pre-Sequencing
  • 8.4. Sequencing

9. Short-read Sequencing Market, by Application

  • 9.1. Introduction
  • 9.2. Agrigenomics & Forensics
  • 9.3. Clinical Investigation
  • 9.4. Consumer Genomics
  • 9.5. HLA Typing & Immune System Monitoring
  • 9.6. Metagenomics, Epidemiology & Drug Development
  • 9.7. Oncology
  • 9.8. Reproductive Health

10. Short-read Sequencing Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Research
  • 10.3. Clinical Research
  • 10.4. Hospitals & Clinics
  • 10.5. Pharma & Biotech Entities

11. Americas Short-read Sequencing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Short-read Sequencing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Short-read Sequencing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Almac Group
  • 4. Azenta Life Sciences
  • 5. BGI Genomics Co., Ltd.
  • 6. Eurofins Genomics LLC
  • 7. F. Hoffmann La Roche AG
  • 8. General Electric Company
  • 9. Genexa AG
  • 10. GenScript Biotech Corporation
  • 11. Illumina, Inc.
  • 12. PerkinElmer, Inc.
  • 13. Qiagen N.V.
  • 14. Seven Bridges Genomics, Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. SHORT-READ SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. SHORT-READ SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SHORT-READ SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SHORT-READ SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HLA TYPING & IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023